Ajax Health-backed Ablacon announced that it closed a Series B financing round worth $30 million with a new lead investor. Zeus Health joined as the new lead investor in the financing, while the company announced that Beaumont Health (Royal Oak, Mich.) Heart Rhythm Center director Dr. David Haines was appointed to Ablacon’s scientific advisory board, […]
ablacon
Ablacon raises another $12m
Ablacon (Menlo Park, Calif.) announced this week that it has secured a $10 million venture debt facility from Western Technology Investment (WTI), accompanied by a $2 million equity investment. The money will help fund the first multicenter randomized clinical trial for Ablamap, Ablacon’s mapping system to guide the treatment of people with atrial fibrillation. “WTI […]
AFib treatment mapping tech dev Ablacon raises $22m
Early-stage cardiovascular tech developer Ablacon said today that it closed a $21.5 million Series A financing round to support its advanced mapping system intended for use in treating atrial fibrillation. Ablacon’s platform uses a novel algorithm and artificial intelligence to analyze and visualize the flow of action potentials within the heart to identify sources and […]
